Literature DB >> 7516787

Detection of HCV RNA in subjects with antibody to hepatitis C virus among the general population of Fukuoka, Japan.

J Hayashi1, K Nakashima, E Yoshimura, M Hirata, Y Maeda, S Kashiwagi.   

Abstract

Volunteer blood donors and aged people who came to hospitals for a thorough physical checkup were surveyed to evaluate the exact prevalence of hepatitis C virus (HCV) infection in the general population of Fukuoka, Japan. We tested for antibody to HCV (anti-HCV) by second-generation assay and, to distinguish active HCV infection from past resolved infection, we tested for HCV RNA in reactive serum samples by polymerase chain reaction. The prevalence of anti-HCV was 286 (2.0%) of 14,341 subjects, increasing with advancing age, from 0.4% in the under-29 age group to 12.0% in the over-70 age group. There were no differences between sexes. HCV RNA was detected in 170 of 286 (59.4%) anti-HCV-positive subjects. The ratio of HCV RNA-positive to anti-HCV-positive subjects was higher in males than in females (P < 0.05) and decreased with advancing age, from 72.2% to 46.5%. The prevalence of elevated alanine aminotransferase (ALT) was only 15.9% in subjects with HCV RNA, higher in males (21.4%) than in females (8.3%) (P < 0.05). This study revealed that the prevalence of anti-HCV was high in the aged population, but that the ratio of HCV RNA-positive to anti-HCV-positive subjects was low, and most of the HCV RNA-positive subjects had normal ALT levels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7516787     DOI: 10.1007/bf02358675

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  20 in total

1.  Hepatitis C virus RNA in symptomless donors implicated in post-transfusion non-A, non-B hepatitis.

Authors:  A R Zanetti; E Tanzi; G Zehender; E Magni; C Incarbone; A Zonaro; D Primi; E Cariani
Journal:  Lancet       Date:  1990-08-18       Impact factor: 79.321

2.  Prevalence of anti-HCV antibody in blood donors in the Tokyo area.

Authors:  J Watanabe; K Minegishi; T Mitsumori; M Ishifuji; T Oguchi; M Ueda; E Tokunaga; E Tanaka; K Kiyosawa; S Furuta
Journal:  Vox Sang       Date:  1990       Impact factor: 2.144

3.  Antibodies to hepatitis C virus in Italian blood donors.

Authors:  G Sirchia; A Bellobuono; A Giovanetti; M Marconi
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

4.  Antibody to hepatitis C virus in German blood donors.

Authors:  P Kühnl; S Seidl; W Stangel; J Beyer; W Sibrowski; J Flik
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

5.  Histologic observations in human hepatitis non-A, non-B.

Authors:  H P Dienes; H Popper; W Arnold; H Lobeck
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

6.  Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay.

Authors:  C L Van der Poel; H T Cuypers; H W Reesink; A J Weiner; S Quan; R Di Nello; J J Van Boven; I Winkel; D Mulder-Folkerts; P J Exel-Oehlers
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

7.  Improved detection of antibodies to hepatitis C virus by the second-generation assay in patients with chronic non-A, non-B liver disease.

Authors:  J Hayashi; K Nakashima; Y Kishihara; M Ohmiya; E Yoshimura; M Hirata; S Kashiwagi
Journal:  J Infect       Date:  1993-05       Impact factor: 6.072

8.  Hepatitis C virus detection is facilitated by the combined use of c100 protein and GOR epitope.

Authors:  J Hayashi; K Nakashima; M Hirata; A Noguchi; K Akazawa; Y Maeda; S Kashiwagi
Journal:  Gastroenterol Jpn       Date:  1992-10

9.  Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells.

Authors:  J T Wang; J C Sheu; J T Lin; T H Wang; D S Chen
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

10.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

View more
  2 in total

1.  Evaluation of quantitative assay for antibody to hepatitis C virus core in patients treated with interferon.

Authors:  E Yoshimura; J Hayashi; Y Kishihara; K Yamaji; N Kinukawa; S Kashiwagi
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

2.  Serum levels of soluble interleukin-2 receptors and effects of interferon-alpha for patients with chronic hepatitis C virus.

Authors:  J Hayashi; Y Kishihara; K Yamaji; E Yoshimura; M Ohmiya; Y Tani; H Ikematsu; S Kashiwagi
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.